Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Increased risk of breast cancer among young women treated with radiation as a ch...
Dr Chaya Moskowitz - Memorial Sloan-Kettering Cancer Center, New York, USA
Increased risk of breast cancer among young women treated with radiation as a child ( Dr Chaya Moskowitz - Memorial Sloan-Kettering Cancer Center, New York, USA )
4 Jun 2012
First effective treatment for chemotherapy-induced peripheral neuropathy
Dr Ellen Lavoie Smith - University of Michigan, Ann Arbor, USA
First effective treatment for chemotherapy-induced peripheral neuropathy ( Dr Ellen Lavoie Smith - University of Michigan, Ann Arbor, USA )
4 Jun 2012
Regorafenib effective for GISTs that progress due to resistance to approved targ...
Dr George Demetri - Dana Farber Cancer Institute, Boston, USA
Regorafenib effective for GISTs that progress due to resistance to approved targeted therapies ( Dr George Demetri - Dana Farber Cancer Institute, Boston, USA )
4 Jun 2012
Combined chemo-radiation extends survival in patients with anaplastic oligodendr...
Dr Martin Van Den Bent - Erasmus University Medical Center, Rotterdam, Netherlan...
Combined chemo-radiation extends survival in patients with anaplastic oligodendroglial tumours ( Dr Martin Van Den Bent - Erasmus University Medical Center, Rotterdam, Netherlands )
3 Jun 2012
Adding bevacizumab to chemotherapy for platinum-resistant ovarian cancer improve...
Dr Eric Pujade-Lauraine - Université Paris Descartes, France
Adding bevacizumab to chemotherapy for platinum-resistant ovarian cancer improves progression-free survival ( Dr Eric Pujade-Lauraine - Université Paris Descartes, France )
2 Jun 2012
Primary and secondary resistance in colorectal cancer
Dr Silvia Marsoni – The Institute for Cancer Research, Candiolo, Italy
Primary and secondary resistance in colorectal cancer ( Dr Silvia Marsoni – The Institute for Cancer Research, Candiolo, Italy )
21 May 2012
PI3K and the heterogeneity of small tumour breast cancer
Dr Sherene Loi – Jules Bordet Institute, Brussels, Belgium
PI3K and the heterogeneity of small tumour breast cancer ( Dr Sherene Loi – Jules Bordet Institute, Brussels, Belgium )
17 May 2012
Molecularly characterising triple negative breast cancer
Prof Jorge Reis-Filho – Jules Bordet Institute, Brussels, Belgium
Molecularly characterising triple negative breast cancer ( Prof Jorge Reis-Filho – Jules Bordet Institute, Brussels, Belgium )
17 May 2012
Endocrine therapy and endocrine resistant breast cancer
Prof Mitch Dowsett – The Institute for Cancer Research, London, UK
Endocrine therapy and endocrine resistant breast cancer ( Prof Mitch Dowsett – The Institute for Cancer Research, London, UK  )
17 May 2012
Use of metformin against breast cancer
Prof Alastair Thompson – University of Dundee, UK
Use of metformin against breast cancer  ( Prof Alastair Thompson – University of Dundee, UK )
17 May 2012
Implementing symptom guidelines
Anita Margulies - EONS and the Swiss Oncology Nursing Society
Implementing symptom guidelines ( Anita Margulies	 - EONS and the Swiss Oncology Nursing Society )
14 May 2012
Involving patients in care decisions
Dr Vikki Entwistle – University of Dundee, UK
Involving patients in care decisions ( Dr Vikki Entwistle – University of Dundee, UK )
11 May 2012